COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-UpBehnood Bikdeli, Gregory Y.H. Lip, Liang Tang et al.|Journal of the American College of Cardiology|2020Cited by 2.9k
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19Aakriti Gupta, Sahil A. Parikh, Mahesh V. Madhavan et al.|Nature Communications|2021Cited by 194
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trialsMattía Galli, Dominick J. Angiolillo, Stefano Benenati et al.|European Heart Journal|2021Cited by 150
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trialsLuis Ortega‐Paz, Dominick J. Angiolillo, Mattía Galli et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2021Cited by 72
Association Between Antecedent Statin Use and Decreased Mortality in Hospitalized Patients with COVID-19Aakriti Gupta, Sahil A. Parikh, Mahesh V. Madhavan et al.|Research Square|2020Cited by 47